Xiaofeng Zhou, PhD

Pfizer Inc

Poster(s):

• (287) A Replication of the Incidence Rate Estimates of Selected Adverse Events of Special Interest (AESIs) from the vACCine covid-19 monitoring readinESS (ACCESS) in the EU with US Real World Data
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (153) Data Source Heterogeneity in Multi-Data Base Pharmacoepidemiologic Studies: An ISPE-sponsored Scoping Review
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (163) Development and Evaluation of The Algorithm Certainty Tool KIT (ACE-IT) to Evaluate Safety Outcomes Using Electronic Medical Record and Claims-Based Algorithms
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (AM) Natural History of Wilson's Disease in the United States Using Optum® Electronic Health Records
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (113) Racial Disparities in COVID-19 Outcomes Among Patients with Rheumatic Arthritis (RA) – a Population Based Study Using US EHR Data
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST